Key Insights
The North America pharmaceutical plastic packaging market, valued at $16.51 billion in 2025, is projected to experience robust growth, driven by several key factors. The increasing demand for pharmaceutical products, coupled with the rising adoption of convenient and cost-effective plastic packaging solutions, significantly fuels market expansion. Furthermore, stringent regulatory requirements for drug safety and efficacy necessitate the use of high-quality, tamper-evident packaging, boosting the demand for specialized plastic packaging options. Technological advancements in plastic materials, such as the development of biodegradable and recyclable plastics, are also shaping market dynamics. This trend is fueled by growing environmental concerns and a push towards sustainable packaging solutions within the pharmaceutical industry. The market is segmented by packaging type (bottles, vials, blister packs, etc.), material type (PET, HDPE, PP, etc.), and application (tablets, capsules, injectables, etc.). Leading players like Gerresheimer AG, Amcor, and Berry Global are actively investing in research and development to enhance their product offerings and meet the evolving needs of the pharmaceutical sector. Competitive pricing strategies and strategic partnerships further contribute to the market's dynamic nature.
The projected Compound Annual Growth Rate (CAGR) of 5.97% from 2025 to 2033 suggests a continuous expansion of the market. This growth is anticipated to be driven by factors such as the increasing prevalence of chronic diseases, necessitating higher drug consumption and packaging, alongside a growing preference for single-dose and convenient packaging formats. However, fluctuating raw material prices and environmental concerns related to plastic waste represent potential market restraints. The industry is addressing these challenges through innovation in sustainable materials and improved recycling infrastructure. Regional variations in growth rates are expected, with North America maintaining a significant market share due to high pharmaceutical consumption and advanced healthcare infrastructure. The market's future trajectory will hinge on ongoing regulatory developments, technological advancements, and the success of sustainability initiatives within the pharmaceutical and packaging sectors.

North America Pharmaceutical Plastic Packaging Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the North America pharmaceutical plastic packaging market, offering invaluable insights for stakeholders across the pharmaceutical and packaging industries. The study covers the period from 2019 to 2033, with a focus on the forecast period from 2025 to 2033 and a base year of 2025. The report utilizes extensive data analysis to deliver actionable intelligence for strategic decision-making. Key players profiled include Gerresheimer AG, Amcor Group GmbH, Berry Global Group Inc, Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, James Alexander Corporation, Drug Plastics Group, Pretium Packaging, Bormioli Pharma United States Inc (Bormioli Pharma S p A), and Silgan Plastics (Silgan Holdings Inc), though the list is not exhaustive. The market is segmented by various factors (detailed within the report), allowing for granular analysis of specific niches and growth potentials.
North America Pharmaceutical Plastic Packaging Market Market Structure & Competitive Dynamics
The North American pharmaceutical plastic packaging market exhibits a moderately consolidated structure, with a few major players holding significant market share. The market is characterized by intense competition, driven by ongoing innovation, stringent regulatory frameworks, and the increasing demand for sustainable and eco-friendly packaging solutions. Innovation ecosystems are thriving, particularly around recyclable and reusable materials like HDPE and rPET. Mergers and acquisitions (M&A) activity has been significant, with deal values reaching xx Million in recent years, primarily focused on expanding product portfolios and geographical reach.
- Market Concentration: The top 5 players account for approximately xx% of the market share in 2025.
- Innovation Ecosystems: Focus is on sustainable materials, improved barrier properties, and smart packaging technologies.
- Regulatory Frameworks: Stringent FDA and other regional regulations drive innovation in safety and compliance.
- Product Substitutes: While plastic remains dominant, bioplastics and alternative materials are gaining traction.
- End-User Trends: Demand is driven by increasing pharmaceutical production, personalized medicine, and e-commerce growth.
- M&A Activities: Strategic acquisitions aim to expand product lines and market presence, boosting overall market value.
North America Pharmaceutical Plastic Packaging Market Industry Trends & Insights
The North American pharmaceutical plastic packaging market is experiencing robust growth, fueled by several key factors. The market is expected to witness a CAGR of xx% during the forecast period (2025-2033). Rising healthcare expenditure, increasing demand for pharmaceutical products, and the growing adoption of innovative packaging solutions are driving market expansion. Technological disruptions, particularly in material science and automation, are creating new opportunities for enhanced efficiency and sustainability. Consumer preferences are shifting towards convenient, tamper-evident, and environmentally responsible packaging. Intense competition is fostering innovation and driving down prices, creating a dynamic and evolving market landscape. Market penetration of sustainable packaging solutions is increasing at a rate of xx% annually.

Dominant Markets & Segments in North America Pharmaceutical Plastic Packaging Market
The United States represents the largest market within North America, driven by factors such as a robust pharmaceutical industry, high healthcare spending, and advanced healthcare infrastructure. The blister packaging segment currently holds the largest market share due to its widespread use for solid dosage forms.
- Key Drivers in the US Market:
- High pharmaceutical consumption and manufacturing.
- Advanced healthcare infrastructure and strong regulatory framework.
- Significant investments in R&D and technological advancements.
- Growing preference for convenient and tamper-evident packaging.
The dominance of the US market is attributable to its large population, high disposable incomes, and a well-established pharmaceutical industry. Other segments, such as bottles and vials, and closures are also experiencing significant growth, driven by the increasing demand for liquid and injectable pharmaceuticals.
North America Pharmaceutical Plastic Packaging Market Product Innovations
Recent innovations focus on sustainable and eco-friendly materials, such as recycled polyethylene (rPE) and polypropylene (rPP), alongside improved barrier properties to enhance product shelf life. Lightweight designs are also gaining popularity to reduce material usage and transportation costs. Smart packaging technologies incorporating features like tamper evidence and track-and-trace capabilities are also being adopted to enhance supply chain security and patient safety. These innovations cater to the growing demands for sustainability and enhanced product security within the pharmaceutical industry.
Report Segmentation & Scope
The report segments the North America pharmaceutical plastic packaging market by packaging type (blister packs, bottles & vials, tubes, pouches, and others), material type (polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), and others), application (tablets & capsules, liquids & injectables, and others), and end-user (hospitals & clinics, pharmaceutical companies, and others). Each segment's growth projections, market sizes, and competitive dynamics are analyzed in detail, providing a comprehensive understanding of market structure and future opportunities. Growth is expected to be fastest in sustainable packaging materials.
Key Drivers of North America Pharmaceutical Plastic Packaging Market Growth
Several factors are driving market growth. The rising prevalence of chronic diseases is increasing the demand for pharmaceutical products, necessitating increased packaging needs. Furthermore, technological advancements in packaging materials and manufacturing processes are improving efficiency and reducing costs. Government regulations focused on product safety and environmental sustainability are also shaping the market. Finally, increasing consumer awareness of eco-friendly packaging choices is boosting the adoption of sustainable solutions.
Challenges in the North America Pharmaceutical Plastic Packaging Market Sector
The industry faces challenges like fluctuating raw material prices, stringent regulatory compliance requirements, and the need to balance sustainability with performance. Supply chain disruptions can also significantly impact production and delivery timelines. Competitive pressure from both domestic and international players necessitates continuous innovation and cost optimization. The market is experiencing a xx% increase in regulatory compliance costs, impacting profitability.
Leading Players in the North America Pharmaceutical Plastic Packaging Market Market
- Gerresheimer AG
- Amcor Group GmbH
- Berry Global Group Inc
- Comar LLC
- Klockner Pentaplast Group
- Nipro Medical Corporation
- James Alexander Corporation
- Drug Plastics Group
- Pretium Packaging
- Bormioli Pharma United States Inc (Bormioli Pharma S p A)
- Silgan Plastics (Silgan Holdings Inc)
- *List Not Exhaustive
Key Developments in North America Pharmaceutical Plastic Packaging Market Sector
- July 2024: Amcor Group GmbH's AmSky™ and AmPrima™ recognition leads to placement on Walmart’s Circular Connector platform. AmSky, a PVC and aluminum-free recycle-ready blister pack, disrupts the standard drug pack using HDPE. AmPrima offers recycle-ready solutions for solid and liquid contents. This significantly enhances the company's market positioning within the sustainable packaging sector.
- April 2024: Berry Global Group, Inc. launches a lightweight tube closure solution made from virgin or recycled PE and PP, reducing greenhouse gas emissions and enhancing sustainability in personal care and pharmaceutical applications. This move signifies a market shift towards eco-conscious packaging solutions.
Strategic North America Pharmaceutical Plastic Packaging Market Market Outlook
The North American pharmaceutical plastic packaging market presents significant growth opportunities, particularly in sustainable packaging solutions. Companies investing in innovative, eco-friendly materials and technologies, while maintaining regulatory compliance, are poised to capture substantial market share. Strategic partnerships and collaborations can accelerate the adoption of innovative packaging solutions and enhance overall market growth. Further market expansion is expected driven by the increasing demand for convenient, tamper-evident, and sustainable packaging solutions.
North America Pharmaceutical Plastic Packaging Market Segmentation
-
1. Raw Material
- 1.1. Polypropylene (PP)
- 1.2. Polyethylene Terephthalate (PET)
- 1.3. Low Density Polyethylene (LDPE)
- 1.4. High Density Polyethylene (HDPE)
- 1.5. Other Raw Materials
-
2. Product Type**
- 2.1. Solid Containers
- 2.2. Dropper Bottles
- 2.3. Nasal Spray Bottles
- 2.4. Liquid Bottles
- 2.5. Oral Care
- 2.6. Pouches
- 2.7. Vials and Ampoules
- 2.8. Cartridges
- 2.9. Syringes
- 2.10. Caps and Closure
- 2.11. Other Product Types
North America Pharmaceutical Plastic Packaging Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico

North America Pharmaceutical Plastic Packaging Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.97% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.3. Market Restrains
- 3.3.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.4. Market Trends
- 3.4.1. Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Pharmaceutical Plastic Packaging Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 5.1.1. Polypropylene (PP)
- 5.1.2. Polyethylene Terephthalate (PET)
- 5.1.3. Low Density Polyethylene (LDPE)
- 5.1.4. High Density Polyethylene (HDPE)
- 5.1.5. Other Raw Materials
- 5.2. Market Analysis, Insights and Forecast - by Product Type**
- 5.2.1. Solid Containers
- 5.2.2. Dropper Bottles
- 5.2.3. Nasal Spray Bottles
- 5.2.4. Liquid Bottles
- 5.2.5. Oral Care
- 5.2.6. Pouches
- 5.2.7. Vials and Ampoules
- 5.2.8. Cartridges
- 5.2.9. Syringes
- 5.2.10. Caps and Closure
- 5.2.11. Other Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Gerresheimer AG
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Amcor Group GmbH
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Berry Global Group Inc
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Comar LLC
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Klockner Pentaplast Group
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Nipro Medical Corporation
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 James Alexander Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Drug Plastics Group
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Pretium Packaging
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Bormioli Pharma United States Inc (Bormioli Pharma S p A )
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.1 Gerresheimer AG
List of Figures
- Figure 1: North America Pharmaceutical Plastic Packaging Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: North America Pharmaceutical Plastic Packaging Market Share (%) by Company 2024
List of Tables
- Table 1: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 4: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 5: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2019 & 2032
- Table 6: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2019 & 2032
- Table 7: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 9: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 10: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 11: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2019 & 2032
- Table 12: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2019 & 2032
- Table 13: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Country 2019 & 2032
- Table 15: United States North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: United States North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 17: Canada North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Canada North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 19: Mexico North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Mexico North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Pharmaceutical Plastic Packaging Market?
The projected CAGR is approximately 5.97%.
2. Which companies are prominent players in the North America Pharmaceutical Plastic Packaging Market?
Key companies in the market include Gerresheimer AG, Amcor Group GmbH, Berry Global Group Inc, Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, James Alexander Corporation, Drug Plastics Group, Pretium Packaging, Bormioli Pharma United States Inc (Bormioli Pharma S p A ), Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive.
3. What are the main segments of the North America Pharmaceutical Plastic Packaging Market?
The market segments include Raw Material, Product Type**.
4. Can you provide details about the market size?
The market size is estimated to be USD 16.51 Million as of 2022.
5. What are some drivers contributing to market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
6. What are the notable trends driving market growth?
Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers.
7. Are there any restraints impacting market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
8. Can you provide examples of recent developments in the market?
July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. Disrupting the decades-long, over-the-counter standard drug pack, it uses high-density polyethylene (HDPE). AmPrima is a portfolio of recycle-ready packaging solutions for both solid and liquid content.April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution. This innovative closure, crafted from either virgin polyethylene (PE) and polypropylene (PP) or food-safe post-consumer recycled plastics (rPE and rPP), significantly contributes to reducing greenhouse gas emissions. It is particularly suited for personal care and pharmaceutical applications.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Pharmaceutical Plastic Packaging Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Pharmaceutical Plastic Packaging Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Pharmaceutical Plastic Packaging Market?
To stay informed about further developments, trends, and reports in the North America Pharmaceutical Plastic Packaging Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence